| Tag |
First Indicator |
Second Indicator |
Subfields |
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
in00004476921 |
| 005 |
20191202143424.0 |
| 008 |
910305s1991 maua b 001 0 eng c |
| 010 |
|
|
|a 91007026
|
| 020 |
|
|
|a 0792312120
|
| 035 |
|
|
|a (OCoLC)23287814
|
| 035 |
|
|
|9 AAE6122MS
|
| 035 |
|
|
|z (UtOrBLW)15338
|
| 035 |
|
|
|a 26433
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d TMV
|d UtOrBLW
|
| 049 |
|
|
|a TMVM
|c 1
|
| 050 |
1 |
0 |
|a RC271.C5
|b M644 1991
|
| 060 |
|
0 |
|a W1 CA693 v. 57
|a QZ 267 M7184
|
| 082 |
0 |
0 |
|a 616.99/4061
|2 20
|
| 096 |
|
|
|a QZ 267
|b M7184 1991
|
| 245 |
0 |
0 |
|a Molecular and clinical advances in anticancer drug resistance /
|c edited by Robert F. Ozols.
|
| 264 |
|
1 |
|a Boston :
|b Kluwer Academic Publishers,
|c 1991.
|
| 300 |
|
|
|a xii, 308 pages :
|b illustrations ;
|c 25 cm.
|
| 336 |
|
|
|a text
|2 rdacontent
|b txt
|
| 337 |
|
|
|a unmediated
|2 rdamedia
|
| 338 |
|
|
|a volume
|2 rdacarrier
|b nc
|
| 490 |
1 |
|
|a Cancer treatment and research ;
|v CTAR 57
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
2 |
|a Alkylating Agents
|x pharmacology.
|
| 650 |
|
2 |
|a Doxorubicin
|x pharmacology.
|
| 650 |
|
2 |
|a Drug Resistance
|x genetics.
|
| 650 |
|
2 |
|a Membrane Glycoproteins
|x genetics.
|
| 650 |
|
2 |
|a Neoplasms
|x drug therapy.
|
| 650 |
|
2 |
|a Vinblastine
|x pharmacology.
|
| 700 |
1 |
|
|a Ozols, Robert F.
|
| 830 |
|
0 |
|a Cancer treatment and research ;
|v v. 57.
|
| 999 |
|
|
|a MARS
|
| 999 |
f |
f |
|s 1bcf06a4-c081-3218-8fa9-3dfc29b18a4f
|i ce63d82b-7131-3655-9d70-8c8d69702bc5
|t 0
|
| 952 |
f |
f |
|p ric
|a Texas A&M University
|b Rellis Campus
|c Joint Library Facility
|d Remote Storage
|t 0
|e QZ 267 M7184 1991
|h National Library of Medicine classification
|i unmediated -- volume
|m 3238901106910
|
| 998 |
f |
f |
|a QZ 267 M7184 1991
|t 0
|l Remote Storage
|